Evidence map›Paper›PMID 27541609›Full record

ArticleFunctional & integrative genomics2017

miR-216 and miR-217 expression is reduced in transgenic mouse models of pancreatic adenocarcinoma, knockout of miR-216/miR-217 host gene is embryonic lethal.

Ana Clara P Azevedo-Pouly, Dhruvitkumar S Sutaria, Jinmai Jiang, Ola A Elgamal, Foued Amari, David Allard, Paul J Grippo, Vincenzo Coppola, Thomas D Schmittgen

Open access · greenAbstract read
In one paragraph

Article in Functional & integrative genomics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Ana Clara P Azevedo-PoulyCollege of Pharmacy, The Ohio State University, Columbus, OH, USA.
Dhruvitkumar S SutariaCollege of Pharmacy, The Ohio State University, Columbus, OH, USA.
Jinmai JiangDepartment of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, FL, USA.
Ola A ElgamalCollege of Pharmacy, The Ohio State University, Columbus, OH, USA.
Foued AmariCollege of Medicine, The Ohio State University, Columbus, OH, USA.
David AllardCambridge University, Cambridge, UK.
Paul J GrippoDepartment of Medicine, University of Illinois Chicago, Chicago, IL, USA.
Vincenzo CoppolaCollege of Medicine, The Ohio State University, Columbus, OH, USA.
Thomas D SchmittgenDepartment of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, FL, USA. tschmittgen@ufl.edu.
The Ohio State University · USUniversity of Florida · USThe University of Texas Southwestern Medical Center · USUniversity of Cambridge · GBUniversity of Illinois Chicago · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
TGF-Beta signaling and microRNA processing: Implications for invasion and metastaF31CA142238 · NCI · OHIO STATE UNIVERSITY · PI AZEVEDO-POULY, ANA CLARA PEREIRA · 2009 to 2012
$139k
NCI NIH HHS F31 CA142238NCI NIH HHS P30 CA016058
6 · The paper itself

Abstract

Mice harboring a G12D activating Kras mutation are among the most heavily studied models in the field of pancreatic adenocarcinoma (PDAC) research. miRNAs are differentially expressed in PDAC from patients and mouse models of PDAC. To better understand the relationship that Kras activation has on miRNA expression, we profiled the expression of 629 miRNAs in RNA isolated from the pancreas of control, young, and old P48

Indexed as

Genes, LethalAdenocarcinomaAnimalsMiceMice, TransgenicMicroRNAsPancreatic NeoplasmsMicroRNAsMIRN216 microRNA, mouseMIRN-217 microRNA, mouseKraslncRNAmicroRNAmiR-216amiR-216bmiR-217Pancreatic cancerTransgenic mice

Identifiers

PMID27541609
PMCPMC5316511
OpenAlexW2515800379

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.